Global Piroxicam Market Insights and Forecast to 2028

Global Piroxicam Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Piroxicam Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Suppositories
1.2.3 Injection
1.2.4 Capsule
1.2.5 Patch
1.2.6 Other
1.3 Market by Application
1.3.1 Global Piroxicam Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Tendonitis
1.3.3 Systemic Traumatic Pain
1.3.4 Musculoskeletal Pain
1.3.5 Contraception
1.3.6 Rheumatoid Arthritis
1.3.7 Chronic Infectious Arthritis
1.3.8 Osteoarthritis
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Piroxicam Market Perspective (2017-2028)
2.2 Piroxicam Growth Trends by Region
2.2.1 Piroxicam Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Piroxicam Historic Market Size by Region (2017-2022)
2.2.3 Piroxicam Forecasted Market Size by Region (2023-2028)
2.3 Piroxicam Market Dynamics
2.3.1 Piroxicam Industry Trends
2.3.2 Piroxicam Market Drivers
2.3.3 Piroxicam Market Challenges
2.3.4 Piroxicam Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Piroxicam Players by Revenue
3.1.1 Global Top Piroxicam Players by Revenue (2017-2022)
3.1.2 Global Piroxicam Revenue Market Share by Players (2017-2022)
3.2 Global Piroxicam Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Piroxicam Revenue
3.4 Global Piroxicam Market Concentration Ratio
3.4.1 Global Piroxicam Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Piroxicam Revenue in 2021
3.5 Piroxicam Key Players Head office and Area Served
3.6 Key Players Piroxicam Product Solution and Service
3.7 Date of Enter into Piroxicam Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Piroxicam Breakdown Data by Type
4.1 Global Piroxicam Historic Market Size by Type (2017-2022)
4.2 Global Piroxicam Forecasted Market Size by Type (2023-2028)
5 Piroxicam Breakdown Data by Application
5.1 Global Piroxicam Historic Market Size by Application (2017-2022)
5.2 Global Piroxicam Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Piroxicam Market Size (2017-2028)
6.2 North America Piroxicam Market Size by Type
6.2.1 North America Piroxicam Market Size by Type (2017-2022)
6.2.2 North America Piroxicam Market Size by Type (2023-2028)
6.2.3 North America Piroxicam Market Share by Type (2017-2028)
6.3 North America Piroxicam Market Size by Application
6.3.1 North America Piroxicam Market Size by Application (2017-2022)
6.3.2 North America Piroxicam Market Size by Application (2023-2028)
6.3.3 North America Piroxicam Market Share by Application (2017-2028)
6.4 North America Piroxicam Market Size by Country
6.4.1 North America Piroxicam Market Size by Country (2017-2022)
6.4.2 North America Piroxicam Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Piroxicam Market Size (2017-2028)
7.2 Europe Piroxicam Market Size by Type
7.2.1 Europe Piroxicam Market Size by Type (2017-2022)
7.2.2 Europe Piroxicam Market Size by Type (2023-2028)
7.2.3 Europe Piroxicam Market Share by Type (2017-2028)
7.3 Europe Piroxicam Market Size by Application
7.3.1 Europe Piroxicam Market Size by Application (2017-2022)
7.3.2 Europe Piroxicam Market Size by Application (2023-2028)
7.3.3 Europe Piroxicam Market Share by Application (2017-2028)
7.4 Europe Piroxicam Market Size by Country
7.4.1 Europe Piroxicam Market Size by Country (2017-2022)
7.4.2 Europe Piroxicam Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Piroxicam Market Size (2017-2028)
8.2 Asia-Pacific Piroxicam Market Size by Type
8.2.1 Asia-Pacific Piroxicam Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Piroxicam Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Piroxicam Market Share by Type (2017-2028)
8.3 Asia-Pacific Piroxicam Market Size by Application
8.3.1 Asia-Pacific Piroxicam Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Piroxicam Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Piroxicam Market Share by Application (2017-2028)
8.4 Asia-Pacific Piroxicam Market Size by Region
8.4.1 Asia-Pacific Piroxicam Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Piroxicam Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Piroxicam Market Size (2017-2028)
9.2 Latin America Piroxicam Market Size by Type
9.2.1 Latin America Piroxicam Market Size by Type (2017-2022)
9.2.2 Latin America Piroxicam Market Size by Type (2023-2028)
9.2.3 Latin America Piroxicam Market Share by Type (2017-2028)
9.3 Latin America Piroxicam Market Size by Application
9.3.1 Latin America Piroxicam Market Size by Application (2017-2022)
9.3.2 Latin America Piroxicam Market Size by Application (2023-2028)
9.3.3 Latin America Piroxicam Market Share by Application (2017-2028)
9.4 Latin America Piroxicam Market Size by Country
9.4.1 Latin America Piroxicam Market Size by Country (2017-2022)
9.4.2 Latin America Piroxicam Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Piroxicam Market Size (2017-2028)
10.2 Middle East & Africa Piroxicam Market Size by Type
10.2.1 Middle East & Africa Piroxicam Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Piroxicam Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Piroxicam Market Share by Type (2017-2028)
10.3 Middle East & Africa Piroxicam Market Size by Application
10.3.1 Middle East & Africa Piroxicam Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Piroxicam Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Piroxicam Market Share by Application (2017-2028)
10.4 Middle East & Africa Piroxicam Market Size by Country
10.4.1 Middle East & Africa Piroxicam Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Piroxicam Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Piroxicam Introduction
11.1.4 Pfizer Revenue in Piroxicam Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Piroxicam Introduction
11.2.4 Teva Revenue in Piroxicam Business (2017-2022)
11.2.5 Teva Recent Developments
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Piroxicam Introduction
11.3.4 Mylan Revenue in Piroxicam Business (2017-2022)
11.3.5 Mylan Recent Developments
11.4 Nostrum
11.4.1 Nostrum Company Details
11.4.2 Nostrum Business Overview
11.4.3 Nostrum Piroxicam Introduction
11.4.4 Nostrum Revenue in Piroxicam Business (2017-2022)
11.4.5 Nostrum Recent Developments
11.5 DCPC
11.5.1 DCPC Company Details
11.5.2 DCPC Business Overview
11.5.3 DCPC Piroxicam Introduction
11.5.4 DCPC Revenue in Piroxicam Business (2017-2022)
11.5.5 DCPC Recent Developments
11.6 FANGMING
11.6.1 FANGMING Company Details
11.6.2 FANGMING Business Overview
11.6.3 FANGMING Piroxicam Introduction
11.6.4 FANGMING Revenue in Piroxicam Business (2017-2022)
11.6.5 FANGMING Recent Developments
11.7 JINGHUA
11.7.1 JINGHUA Company Details
11.7.2 JINGHUA Business Overview
11.7.3 JINGHUA Piroxicam Introduction
11.7.4 JINGHUA Revenue in Piroxicam Business (2017-2022)
11.7.5 JINGHUA Recent Developments
11.8 JUMPCAN
11.8.1 JUMPCAN Company Details
11.8.2 JUMPCAN Business Overview
11.8.3 JUMPCAN Piroxicam Introduction
11.8.4 JUMPCAN Revenue in Piroxicam Business (2017-2022)
11.8.5 JUMPCAN Recent Developments
11.9 Technilab Pharma
11.9.1 Technilab Pharma Company Details
11.9.2 Technilab Pharma Business Overview
11.9.3 Technilab Pharma Piroxicam Introduction
11.9.4 Technilab Pharma Revenue in Piroxicam Business (2017-2022)
11.9.5 Technilab Pharma Recent Developments
11.10 Apotex Corporation
11.10.1 Apotex Corporation Company Details
11.10.2 Apotex Corporation Business Overview
11.10.3 Apotex Corporation Piroxicam Introduction
11.10.4 Apotex Corporation Revenue in Piroxicam Business (2017-2022)
11.10.5 Apotex Corporation Recent Developments
11.11 Keltman Pharmaceuticals
11.11.1 Keltman Pharmaceuticals Company Details
11.11.2 Keltman Pharmaceuticals Business Overview
11.11.3 Keltman Pharmaceuticals Piroxicam Introduction
11.11.4 Keltman Pharmaceuticals Revenue in Piroxicam Business (2017-2022)
11.11.5 Keltman Pharmaceuticals Recent Developments
11.12 Genpharm
11.12.1 Genpharm Company Details
11.12.2 Genpharm Business Overview
11.12.3 Genpharm Piroxicam Introduction
11.12.4 Genpharm Revenue in Piroxicam Business (2017-2022)
11.12.5 Genpharm Recent Developments
11.13 Bayer
11.13.1 Bayer Company Details
11.13.2 Bayer Business Overview
11.13.3 Bayer Piroxicam Introduction
11.13.4 Bayer Revenue in Piroxicam Business (2017-2022)
11.13.5 Bayer Recent Developments
11.14 PLX Pharma
11.14.1 PLX Pharma Company Details
11.14.2 PLX Pharma Business Overview
11.14.3 PLX Pharma Piroxicam Introduction
11.14.4 PLX Pharma Revenue in Piroxicam Business (2017-2022)
11.14.5 PLX Pharma Recent Developments
11.15 Chiesi
11.15.1 Chiesi Company Details
11.15.2 Chiesi Business Overview
11.15.3 Chiesi Piroxicam Introduction
11.15.4 Chiesi Revenue in Piroxicam Business (2017-2022)
11.15.5 Chiesi Recent Developments
11.16 SK Chemicals
11.16.1 SK Chemicals Company Details
11.16.2 SK Chemicals Business Overview
11.16.3 SK Chemicals Piroxicam Introduction
11.16.4 SK Chemicals Revenue in Piroxicam Business (2017-2022)
11.16.5 SK Chemicals Recent Developments
11.17 Bioglan Laboratories
11.17.1 Bioglan Laboratories Company Details
11.17.2 Bioglan Laboratories Business Overview
11.17.3 Bioglan Laboratories Piroxicam Introduction
11.17.4 Bioglan Laboratories Revenue in Piroxicam Business (2017-2022)
11.17.5 Bioglan Laboratories Recent Developments
11.18 APR
11.18.1 APR Company Details
11.18.2 APR Business Overview
11.18.3 APR Piroxicam Introduction
11.18.4 APR Revenue in Piroxicam Business (2017-2022)
11.18.5 APR Recent Developments
11.19 CJ HealthCare
11.19.1 CJ HealthCare Company Details
11.19.2 CJ HealthCare Business Overview
11.19.3 CJ HealthCare Piroxicam Introduction
11.19.4 CJ HealthCare Revenue in Piroxicam Business (2017-2022)
11.19.5 CJ HealthCare Recent Developments
11.20 SkyePharma
11.20.1 SkyePharma Company Details
11.20.2 SkyePharma Business Overview
11.20.3 SkyePharma Piroxicam Introduction
11.20.4 SkyePharma Revenue in Piroxicam Business (2017-2022)
11.20.5 SkyePharma Recent Developments
11.21 Changzhou Siyao Pharmaceutical
11.21.1 Changzhou Siyao Pharmaceutical Company Details
11.21.2 Changzhou Siyao Pharmaceutical Business Overview
11.21.3 Changzhou Siyao Pharmaceutical Piroxicam Introduction
11.21.4 Changzhou Siyao Pharmaceutical Revenue in Piroxicam Business (2017-2022)
11.21.5 Changzhou Siyao Pharmaceutical Recent Developments
11.22 Shanxi Yunpeng Pharmaceutical
11.22.1 Shanxi Yunpeng Pharmaceutical Company Details
11.22.2 Shanxi Yunpeng Pharmaceutical Business Overview
11.22.3 Shanxi Yunpeng Pharmaceutical Piroxicam Introduction
11.22.4 Shanxi Yunpeng Pharmaceutical Revenue in Piroxicam Business (2017-2022)
11.22.5 Shanxi Yunpeng Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Piroxicam Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Suppositories
Table 3. Key Players of Injection
Table 4. Key Players of Capsule
Table 5. Key Players of Patch
Table 6. Key Players of Other
Table 7. Global Piroxicam Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Piroxicam Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Piroxicam Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Piroxicam Market Share by Region (2017-2022)
Table 11. Global Piroxicam Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Piroxicam Market Share by Region (2023-2028)
Table 13. Piroxicam Market Trends
Table 14. Piroxicam Market Drivers
Table 15. Piroxicam Market Challenges
Table 16. Piroxicam Market Restraints
Table 17. Global Piroxicam Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Piroxicam Revenue Share by Players (2017-2022)
Table 19. Global Top Piroxicam by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Piroxicam as of 2021)
Table 20. Ranking of Global Top Piroxicam Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Piroxicam Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Piroxicam Product Solution and Service
Table 24. Date of Enter into Piroxicam Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Piroxicam Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Piroxicam Revenue Market Share by Type (2017-2022)
Table 28. Global Piroxicam Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Piroxicam Revenue Market Share by Type (2023-2028)
Table 30. Global Piroxicam Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Piroxicam Revenue Share by Application (2017-2022)
Table 32. Global Piroxicam Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Piroxicam Revenue Share by Application (2023-2028)
Table 34. North America Piroxicam Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Piroxicam Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Piroxicam Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Piroxicam Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Piroxicam Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Piroxicam Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Piroxicam Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Piroxicam Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Piroxicam Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Piroxicam Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Piroxicam Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Piroxicam Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Piroxicam Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Piroxicam Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Piroxicam Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Piroxicam Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Piroxicam Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Piroxicam Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Piroxicam Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Piroxicam Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Piroxicam Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Piroxicam Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Piroxicam Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Piroxicam Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Piroxicam Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Piroxicam Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Piroxicam Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Piroxicam Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Piroxicam Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Piroxicam Market Size by Country (2023-2028) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Piroxicam Product
Table 67. Pfizer Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 68. Pfizer Recent Developments
Table 69. Teva Company Details
Table 70. Teva Business Overview
Table 71. Teva Piroxicam Product
Table 72. Teva Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 73. Teva Recent Developments
Table 74. Mylan Company Details
Table 75. Mylan Business Overview
Table 76. Mylan Piroxicam Product
Table 77. Mylan Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 78. Mylan Recent Developments
Table 79. Nostrum Company Details
Table 80. Nostrum Business Overview
Table 81. Nostrum Piroxicam Product
Table 82. Nostrum Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 83. Nostrum Recent Developments
Table 84. DCPC Company Details
Table 85. DCPC Business Overview
Table 86. DCPC Piroxicam Product
Table 87. DCPC Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 88. DCPC Recent Developments
Table 89. FANGMING Company Details
Table 90. FANGMING Business Overview
Table 91. FANGMING Piroxicam Product
Table 92. FANGMING Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 93. FANGMING Recent Developments
Table 94. JINGHUA Company Details
Table 95. JINGHUA Business Overview
Table 96. JINGHUA Piroxicam Product
Table 97. JINGHUA Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 98. JINGHUA Recent Developments
Table 99. JUMPCAN Company Details
Table 100. JUMPCAN Business Overview
Table 101. JUMPCAN Piroxicam Product
Table 102. JUMPCAN Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 103. JUMPCAN Recent Developments
Table 104. Technilab Pharma Company Details
Table 105. Technilab Pharma Business Overview
Table 106. Technilab Pharma Piroxicam Product
Table 107. Technilab Pharma Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 108. Technilab Pharma Recent Developments
Table 109. Apotex Corporation Company Details
Table 110. Apotex Corporation Business Overview
Table 111. Apotex Corporation Piroxicam Product
Table 112. Apotex Corporation Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 113. Apotex Corporation Recent Developments
Table 114. Keltman Pharmaceuticals Company Details
Table 115. Keltman Pharmaceuticals Business Overview
Table 116. Keltman Pharmaceuticals Piroxicam Product
Table 117. Keltman Pharmaceuticals Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 118. Keltman Pharmaceuticals Recent Developments
Table 119. Genpharm Company Details
Table 120. Genpharm Business Overview
Table 121. Genpharm Piroxicam Product
Table 122. Genpharm Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 123. Genpharm Recent Developments
Table 124. Bayer Company Details
Table 125. Bayer Business Overview
Table 126. Bayer Piroxicam Product
Table 127. Bayer Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 128. Bayer Recent Developments
Table 129. PLX Pharma Company Details
Table 130. PLX Pharma Business Overview
Table 131. PLX Pharma Piroxicam Product
Table 132. PLX Pharma Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 133. PLX Pharma Recent Developments
Table 134. Chiesi Company Details
Table 135. Chiesi Business Overview
Table 136. Chiesi Piroxicam Product
Table 137. Chiesi Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 138. Chiesi Recent Developments
Table 139. SK Chemicals Company Details
Table 140. SK Chemicals Business Overview
Table 141. SK Chemicals Piroxicam Product
Table 142. SK Chemicals Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 143. SK Chemicals Recent Developments
Table 144. Bioglan Laboratories Company Details
Table 145. Bioglan Laboratories Business Overview
Table 146. Bioglan Laboratories Piroxicam Product
Table 147. Bioglan Laboratories Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 148. Bioglan Laboratories Recent Developments
Table 149. APR Company Details
Table 150. APR Business Overview
Table 151. APR Piroxicam Product
Table 152. APR Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 153. APR Recent Developments
Table 154. CJ HealthCare Company Details
Table 155. CJ HealthCare Business Overview
Table 156. CJ HealthCare Piroxicam Product
Table 157. CJ HealthCare Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 158. CJ HealthCare Recent Developments
Table 159. SkyePharma Company Details
Table 160. SkyePharma Business Overview
Table 161. SkyePharma Piroxicam Product
Table 162. SkyePharma Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 163. SkyePharma Recent Developments
Table 164. Changzhou Siyao Pharmaceutical Company Details
Table 165. Changzhou Siyao Pharmaceutical Business Overview
Table 166. Changzhou Siyao Pharmaceutical Piroxicam Product
Table 167. Changzhou Siyao Pharmaceutical Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 168. Changzhou Siyao Pharmaceutical Recent Developments
Table 169. Shanxi Yunpeng Pharmaceutical Company Details
Table 170. Shanxi Yunpeng Pharmaceutical Business Overview
Table 171. Shanxi Yunpeng Pharmaceutical Piroxicam Product
Table 172. Shanxi Yunpeng Pharmaceutical Revenue in Piroxicam Business (2017-2022) & (US$ Million)
Table 173. Shanxi Yunpeng Pharmaceutical Recent Developments
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Piroxicam Market Share by Type: 2021 VS 2028
Figure 2. Suppositories Features
Figure 3. Injection Features
Figure 4. Capsule Features
Figure 5. Patch Features
Figure 6. Other Features
Figure 7. Global Piroxicam Market Share by Application: 2021 VS 2028
Figure 8. Tendonitis Case Studies
Figure 9. Systemic Traumatic Pain Case Studies
Figure 10. Musculoskeletal Pain Case Studies
Figure 11. Contraception Case Studies
Figure 12. Rheumatoid Arthritis Case Studies
Figure 13. Chronic Infectious Arthritis Case Studies
Figure 14. Osteoarthritis Case Studies
Figure 15. Other Case Studies
Figure 16. Piroxicam Report Years Considered
Figure 17. Global Piroxicam Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 18. Global Piroxicam Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global Piroxicam Market Share by Region: 2021 VS 2028
Figure 20. Global Piroxicam Market Share by Players in 2021
Figure 21. Global Top Piroxicam Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Piroxicam as of 2021)
Figure 22. The Top 10 and 5 Players Market Share by Piroxicam Revenue in 2021
Figure 23. North America Piroxicam Market Size YoY (2017-2028) & (US$ Million)
Figure 24. North America Piroxicam Market Size Market Share by Type (2017-2028)
Figure 25. North America Piroxicam Market Size Market Share by Application (2017-2028)
Figure 26. North America Piroxicam Market Size Share by Country (2017-2028)
Figure 27. United States Piroxicam Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Canada Piroxicam Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Europe Piroxicam Market Size YoY (2017-2028) & (US$ Million)
Figure 30. Europe Piroxicam Market Size Market Share by Type (2017-2028)
Figure 31. Europe Piroxicam Market Size Market Share by Application (2017-2028)
Figure 32. Europe Piroxicam Market Size Share by Country (2017-2028)
Figure 33. Germany Piroxicam Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. France Piroxicam Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. U.K. Piroxicam Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Italy Piroxicam Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Russia Piroxicam Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Nordic Countries Piroxicam Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Asia-Pacific Piroxicam Market Size YoY (2017-2028) & (US$ Million)
Figure 40. Asia Pacific Piroxicam Market Size Market Share by Type (2017-2028)
Figure 41. Asia Pacific Piroxicam Market Size Market Share by Application (2017-2028)
Figure 42. Asia Pacific Piroxicam Market Size Share by Region (2017-2028)
Figure 43. China Piroxicam Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Japan Piroxicam Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. South Korea Piroxicam Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Southeast Asia Piroxicam Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. India Piroxicam Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Australia Piroxicam Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 49. Latin America Piroxicam Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Latin America Piroxicam Market Size Market Share by Type (2017-2028)
Figure 51. Latin America Piroxicam Market Size Market Share by Application (2017-2028)
Figure 52. Latin America Piroxicam Market Size Share by Country (2017-2028)
Figure 53. Mexico Piroxicam Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Brazil Piroxicam Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Middle East & Africa Piroxicam Market Size YoY (2017-2028) & (US$ Million)
Figure 56. Middle East and Africa Piroxicam Market Size Market Share by Type (2017-2028)
Figure 57. Middle East and Africa Piroxicam Market Size Market Share by Application (2017-2028)
Figure 58. Middle East and Africa Piroxicam Market Size Share by Country (2017-2028)
Figure 59. Turkey Piroxicam Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia Piroxicam Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 61. UAE Piroxicam Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 62. Pfizer Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 63. Teva Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 64. Mylan Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 65. Nostrum Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 66. DCPC Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 67. FANGMING Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 68. JINGHUA Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 69. JUMPCAN Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 70. Technilab Pharma Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 71. Apotex Corporation Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 72. Keltman Pharmaceuticals Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 73. Genpharm Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 74. Bayer Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 75. PLX Pharma Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 76. Chiesi Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 77. SK Chemicals Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 78. Bioglan Laboratories Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 79. APR Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 80. CJ HealthCare Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 81. SkyePharma Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 82. Changzhou Siyao Pharmaceutical Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 83. Shanxi Yunpeng Pharmaceutical Revenue Growth Rate in Piroxicam Business (2017-2022)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Methylprednisolone Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress The immune system. It is prescribed for a wide range of medical conditions, including autoimmune disorders and inflammatory diseases. The global Methylprednisolone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Methylprednisolone is a widely used medication, and The market trend invol......

Global Ibuprofen Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. The global Ibuprofen market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 112.3 million by 2030, witnessing a CAGR of 2.7% during The forecast period 2024-2030. Market competition is intense. Xinhua Pharmaceutical, IOLCP,......

Global Mesalazine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Mesalazine market size was valued at US$ 158.3 million in 2023. With growing demand in downstream market, the Mesalazine is forecast to a readjusted size of US$ 206 million by 2030 with a CAGR of 3.8% during review period. The research report highlights the growth potential of the global Mesalazine market. Mesalazine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......

Global Drugs For Sinusitis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Drugs For Sinusitis market size was valued at US$ 2187.4 million in 2023. With growing demand in downstream market, the Drugs For Sinusitis is forecast to a readjusted size of US$ 2827.4 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Drugs For Sinusitis market. Drugs For Sinusitis are expected to show stable growth in the future market. However, prod......

Global Celecoxib Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period. The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......

Global Ibuprofen Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100

According to our LPI (LP Information) latest study, the global Ibuprofen market size was valued at US$ 91 million in 2023. With growing demand in downstream market, the Ibuprofen is forecast to a readjusted size of US$ 110.4 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Ibuprofen market. Ibuprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......

Global Ketoprofen Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Ketoprofen market size was valued at US$ 34 million in 2023. With growing demand in downstream market, the Ketoprofen is forecast to a readjusted size of US$ 39 million by 2030 with a CAGR of 2.0% during review period. The research report highlights the growth potential of the global Ketoprofen market. Ketoprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......

Global Drugs for Sinusitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 114

Market Overview of Global Drugs for Sinusitis market: According to our latest research, the global Drugs for Sinusitis market looks promising in the next 5 years. As of 2022, the global Drugs for Sinusitis market was estimated at USD 2147.6 million, and it's anticipated to reach USD 3206.59 million in 2028, with a CAGR of 6.91% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dru......

Global Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91

According to our (Global Info Research) latest study, the global Ibuprofen market size was valued at USD 96 million in 2023 and is forecast to a readjusted size of USD 114.4 million by 2030 with a CAGR of 2.6% during review period. Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. Market competitio......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs